- Home
- RAPP vs GSHD Comparison
RAPP vs GSHD Comparison
Compare RAPP & GSHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | RAPP | GSHD |
|---|---|---|
| Founded | 2022 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Specialty Insurers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RAPP | GSHD |
|---|---|---|
| Price | $41.47 | $45.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $48.50 | ★ $72.50 |
| AVG Volume (30 Days) | ★ 292.3K | 287.0K |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.34 | N/A |
| EPS | N/A | ★ 1.04 |
| Revenue | N/A | ★ $365,304,000.00 |
| Revenue This Year | N/A | $16.40 |
| Revenue Next Year | N/A | $18.53 |
| P/E Ratio | ★ N/A | $49.71 |
| Revenue Growth | N/A | ★ 16.15 |
| 52 Week Low | $23.75 | $33.68 |
| 52 Week High | $52.93 | $79.85 |
Technical Indicators
Market Signals| Indicator | RAPP | GSHD |
|---|---|---|
| Relative Strength Index (RSI) | 27.77 | 26.74 |
| Support Level | $33.54 | $40.71 |
| Resistance Level | $40.61 | $56.00 |
| Average True Range (ATR) | 2.15 | 3.63 |
| MACD | -0.96 | -1.76 |
| Stochastic Oscillator | 0.82 | 2.86 |
Price Performance
Historical ComparisonAbout RAPP Rapport Therapeutics Inc.
Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.
About GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions. The company is has a single reportable segment: insurance distribution.